¹⁸⁸Re-direct labeling of monoclonal antibodies for radioimmunotherapy of solid tumors : Biodistribution, normal organ dosimetry, and toxicologyIZNAGA-ESCOBAR, N.Nuclear medicine and biology. 1998, Vol 25, Num 5, pp 441-447, issn 0969-8051Article

Micromethod for quantification of SH groups generated after reduction of monoclonal antibodiesIZNAGA ESCOBAR, N; MORALES, A; NUNEZ, G et al.Nuclear medicine and biology. 1996, Vol 23, Num 5, pp 641-644, issn 0969-8051Article

A computer program for quantification of SH groups generated after reduction of monoclonal antibodiesIZNAGA ESCOBAR, N; MORALES, A; NUNEZ, G et al.Nuclear medicine and biology. 1996, Vol 23, Num 5, pp 635-639, issn 0969-8051Article

Factors affecting pharmacokinetics of monoclonal antibodies: A review articleIZNAGA-ESCOBAR, N; MISHRA, A. K; PEREZ-RODRIGUEZ, R et al.Methods and findings in experimental and clinical pharmacology. 2004, Vol 26, Num 2, pp 123-127, issn 0379-0355, 5 p.Article

¹⁸⁸Re-labeled antiepidermal growth factor receptor humanized monoclonal antibody h-R3: labeling conditions, in vitro and in vivo stabilityIZNAGA-ESCOBAR, N; RAMIREZ, I. L; IZQUIERDO, J. C et al.Methods and findings in experimental and clinical pharmacology. 2003, Vol 25, Num 9, pp 703-711, issn 0379-0355, 9 p.Article

^99mTc-labeled murine ior C5 monoclonal Antibody in colorectal carcinoma patients: Pharmacokinetics, biodistribution, absorbed Radiation doses to normal organs and tissues and tumor localizationIZNAGA-ESCOBAR, N; RAMOS-SUZARTE, M; MORALES-MORALES, A et al.Methods and findings in experimental and clinical pharmacology. 2004, Vol 26, Num 9, pp 687-696, issn 0379-0355, 10 p.Article

Biodistribution of ^99mTc-labeled anti-human epidermal growth factor receptor (EGF-R) humanized monoclonal antibody h-R3 in a xenograft model of human lung adenocarcinomaMORALES-MORALES, A; DUCONGE, J; CABALLERO-TORRES, I et al.Nuclear medicine and biology. 1999, Vol 26, Num 3, pp 275-279, issn 0969-8051Article

Pharmacokinetics, biodistribution and dosimetry of ^99mTc-labeled anti-human epidermal growth factor receptor humanized monoclonal antibody R3 in ratsIZNAGA ESCOBAR, N; MORALES MORALES, A; DUCONGE, J et al.Nuclear medicine and biology. 1998, Vol 25, Num 1, pp 17-23, issn 0969-8051Article

Construction of an immunotoxin with the pore forming protein StI and ior c5, a monoclonal antibody against a colon cancer cell lineTEJUCA, M; DIAZ, I; FIGUEREDO, R et al.International immunopharmacology. 2004, Vol 4, Num 6, pp 731-744, issn 1567-5769, 14 p.Article

A phase I study of ^99mTc-hR3 (DiaCIM®), a humanized immunoconjugate directed towards the epidermal growth factor receptorVALLIS, K. A; REILLY, R. M; CHEN, P et al.Nuclear medicine communications. 2002, Vol 23, Num 12, pp 1155-1164, issn 0143-3636, 10 p.Article

Radiotoxicity of h-R3 monoclonal antibody labeled with ¹⁸⁸Re administered intracerebrally in ratsGONZALEZ, B; CASACO, A; IZNAGA-ESCOBAR, N et al.Human & experimental toxicology. 2000, Vol 19, Num 12, pp 684-692, issn 0960-3271Article

Humanized versus murine anti-human epidermal growth factor receptor monoclonal antibodies for immunoscintigraphic studiesMORALES MORALES, A. A; DUCONGE, J; ALVAREZ-RUIZ, D et al.Nuclear medicine and biology. 2000, Vol 27, Num 2, pp 199-206, issn 0969-8051Article

Technetium-99m-labeled anti-EGF-receptor antibody in patients with tumor of epithelial origin : I. Biodistribution and dosimetry for radioimmunotherapyIZNAGA-ESCOBAR, N; TORRES, L. A; LAGE, A et al.The Journal of nuclear medicine (1978). 1998, Vol 39, Num 1, pp 15-23, issn 0161-5505Article

Multianalytical system (MAS) : software for enzyme-linked immunosorbent assay (ELISA) data processing with applications to screening and diagnostic testsIZNAGA ESCOBAR, N; ARMSTRONG, J. S; GANDOLFF, G et al.Journal of immunological methods. 1996, Vol 196, Num 1, pp 97-99, issn 0022-1759Article